These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8669885)

  • 1. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.
    Younes M; Brown RW; Mody DR; Fernandez L; Laucirica R
    Anticancer Res; 1995; 15(6B):2895-8. PubMed ID: 8669885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
    Younes M; Juarez D; Lechago LV; Lerner SP
    Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of facilitative glucose transporters in gastric tumors.
    Noguchi Y; Marat D; Saito A; Yoshikawa T; Doi C; Fukuzawa K; Tsuburaya A; Satoh S; Ito T
    Hepatogastroenterology; 1999; 46(28):2683-9. PubMed ID: 10522065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.
    Alò PL; Visca P; Botti C; Galati GM; Sebastiani V; Andreano T; Di Tondo U; Pizer ES
    Am J Clin Pathol; 2001 Jul; 116(1):129-34. PubMed ID: 11447743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers.
    Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J
    Cancer Res; 1996 Mar; 56(5):1164-7. PubMed ID: 8640778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of glucose transporter-1 in Taiwanese patients with breast carcinoma--a preliminary report.
    Kuo SJ; Wu YC; Chen CP; Tseng HS; Chen DR
    Kaohsiung J Med Sci; 2006 Jul; 22(7):339-45. PubMed ID: 16849102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
    Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR
    Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.
    Neri A; Marrelli D; Pedrazzani C; Caruso S; De Stefano A; Mariani F; Megha T; De Marco G; Corso G; Pinto E; Roviello F
    Eur J Surg Oncol; 2008 Dec; 34(12):1299-303. PubMed ID: 18164172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
    Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
    Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma.
    Mineta H; Miura K; Takebayashi S; Misawa K; Araki K; Misawa Y; Ueda Y
    Anticancer Res; 2002; 22(6B):3489-94. PubMed ID: 12552944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
    Younes M; Lechago LV; Lechago J
    Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
    Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival.
    Baer S; Casaubon L; Schwartz MR; Marcogliese A; Younes M
    Laryngoscope; 2002 Feb; 112(2):393-6. PubMed ID: 11889403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
    Rao UN; Finkelstein SD; Jones MW
    Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children.
    Hernández F; Navarro M; Encinas JL; López Gutiérrez JC; López Santamaría M; Leal N; Martínez L; Patrón M; Tovar JA
    J Pediatr Surg; 2005 May; 40(5):801-4. PubMed ID: 15937818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L; Baker H; Sinowatz F
    Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.